☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Large B-cell Lymphoma
Triumvira's TAC01-CD19 Receives FDA's Fast Track Designation for R/R Diffuse Large B-Cell Lymphoma
November 8, 2019
Kite Reports Results of Yescarta (axicabtagene ciloleucel) in ZUMA-1 trial for Refractory Large B-Cell- Lymphoma- Presented at ASH...
December 4, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.